-CNBC’s “Fast Money: Halftime Report”
DBV Technologies To Conduct New Pivotal Trial For Peanut Allergy Patch, Shares Plunge To 52-Week Low
After reviewing the FDA's information requests and considering all other options, DBV Technologies (NASDAQ: DBVT) has